文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嗅神经母细胞瘤的治疗:对361例患者的16年荟萃分析。

Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.

作者信息

Devaiah Anand K, Andreoli Michael T

机构信息

Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

出版信息

Laryngoscope. 2009 Jul;119(7):1412-6. doi: 10.1002/lary.20280.


DOI:10.1002/lary.20280
PMID:19444891
Abstract

OBJECTIVES/HYPOTHESIS: This study reviews the published outcomes related to surgical (open, endoscopic, and endoscopic-assisted) and nonsurgical treatment for esthesioneuroblastoma. STUDY DESIGN: Literature meta-analysis. METHODS: A meta-analysis of individual patient data for esthesioneuroblastoma publications between 1992 (the earliest identified description of endoscopic resection) and 2008 was conducted. A total of 49 journal articles, comprising 1,170 cases of esthesioneuroblastoma, were included in the study. Criteria for meta-analysis inclusion were five or more patients in a study with sufficient patient data resolution for analysis. Twenty-three studies comprising 361 patients met all inclusion criteria. The overall treatment and outcome at final follow-up of each patient was recorded. Patients were pooled according to treatment techniques and compared to one another using a Kaplan-Meier survival curve and the Mann-Whitney U test to examine differences in follow-up times and publication years. RESULTS: Log-rank tests showed a greater published survival rate for endoscopic surgery compared to open surgery (P = .0019), even when stratifying for publication year (P = .0018). There was no significant difference in follow-up time. Review of Kadish tumor staging for each modality showed larger tumors were more often treated with an open approach, but open and endoscopic survival measures were comparable. CONCLUSIONS: These results suggest that endoscopic surgery is a valid treatment method with comparable survival to open surgery. Further prospective analysis will be beneficial.

摘要

目的/假设:本研究回顾了与嗅神经母细胞瘤的手术治疗(开放手术、内镜手术和内镜辅助手术)及非手术治疗相关的已发表结果。 研究设计:文献荟萃分析。 方法:对1992年(最早确定的内镜切除术描述)至2008年间发表的嗅神经母细胞瘤相关文献进行个体患者数据的荟萃分析。该研究共纳入49篇期刊文章,包含1170例嗅神经母细胞瘤病例。荟萃分析纳入标准为研究中至少有5例患者且患者数据分辨率足以进行分析。23项研究共361例患者符合所有纳入标准。记录了每位患者最终随访时的总体治疗情况及结果。根据治疗技术将患者分组,使用Kaplan-Meier生存曲线和Mann-Whitney U检验相互比较,以检验随访时间和发表年份的差异。 结果:对数秩检验显示,与开放手术相比,内镜手术的发表生存率更高(P = 0.0019),即使按发表年份分层时也是如此(P = 0.0018)。随访时间无显著差异。对每种治疗方式的Kadish肿瘤分期进行回顾发现,较大的肿瘤更常采用开放手术治疗,但开放手术和内镜手术的生存指标相当。 结论:这些结果表明,内镜手术是一种有效的治疗方法,其生存率与开放手术相当。进一步的前瞻性分析将有益处。

相似文献

[1]
Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.

Laryngoscope. 2009-7

[2]
Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection.

Laryngoscope. 2003-12

[3]
Esthesioneuroblastoma: 25-year experience at a single institution.

Otolaryngol Head Neck Surg. 2008-4

[4]
Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.

Laryngoscope. 2000-8

[5]
Endoscopic resection of esthesioneuroblastoma.

Am J Rhinol. 2001

[6]
Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma).

Acta Neurochir (Wien). 2005-6

[7]
Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.

Arch Otolaryngol Head Neck Surg. 2007-3

[8]
Patterns of failure and outcome in esthesioneuroblastoma.

Arch Otolaryngol Head Neck Surg. 2003-11

[9]
Endoscopic-assisted craniofacial resection of esthesioneuroblastoma: minimizing facial incisions--technical note and report of 3 cases.

Minim Invasive Neurosurg. 2003-10

[10]
Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study.

Am J Rhinol Allergy. 2009

引用本文的文献

[1]
Endoscopic surgery versus various open approaches in esthesioneuroblastoma: a systematic review of the literature.

Front Oncol. 2025-5-28

[2]
The 100 most-cited papers on esthesioneuroblastoma: a bibliometric analysis.

Ann Med Surg (Lond). 2025-1-21

[3]
Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors.

Cancers (Basel). 2025-1-21

[4]
A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.

Kobe J Med Sci. 2024-6-3

[5]
An expandable chamber for safe brain retraction: new technologies in the field of transcranial endoscopic surgery.

J Zhejiang Univ Sci B. 2023-4-15

[6]
Oncologic outcome of multimodality treatment for sinonasal malignancies: An 18-year experience.

Front Oncol. 2022-9-5

[7]
The Role of Advanced Endoscopic Resection of Diverse Skull Base Malignancies: Technological Analysis during an 8-Year Single Institutional Experience.

J Neurol Surg B Skull Base. 2020-8-5

[8]
Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review.

Case Rep Oncol. 2022-3-10

[9]
Soft Robotic Deployable Origami Actuators for Neurosurgical Brain Retraction.

Front Robot AI. 2022-1-14

[10]
Olfactory Neuroblastoma Managed with Endoscopic Sinus Surgery.

J Pharm Bioallied Sci. 2021-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索